NCT01785160View on ClinicalTrials.gov

Investigation of Faldaprevir Effect on Pharmacokinetics of Raltegravir

PHASE1CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

February 28, 2013

Primary Completion Date

March 31, 2013

Study Completion Date

March 31, 2013

Conditions
Healthy
Interventions
DRUG

Raltegravir

low dose oral administration

DRUG

Raltegravir

low dose oral administration

DRUG

Faldaprevir

medium dose oral administration

Trial Locations (1)

Unknown

1220.65.1 Boehringer Ingelheim Investigational Site, Mannheim

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY